Skip to main content
Erschienen in: Supportive Care in Cancer 12/2018

08.06.2018 | Original Article

Bloodstream infection caused by S. aureus in patients with cancer: a 10-year longitudinal single-center study

verfasst von: Omar Yaxmehen Bello-Chavolla, Jessica Paola Bahena-Lopez, Pamela Garciadiego-Fosass, Patricia Volkow, Alejandro Garcia-Horton, Consuelo Velazquez-Acosta, Diana Vilar-Compte

Erschienen in: Supportive Care in Cancer | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Staphylococcus aureus bloodstream infections (SABIs) represent a significant cause of morbidity and mortality in cancer patients. In this study, we compared infection characteristics and evaluated epidemiology and risk factors associated to SABIs and 30-day attributable mortality in cancer patients.

Methods

Clinical and microbiological data from patients with cancer and positive blood cultures for S. aureus were retrieved during a 10-year period at an oncology reference center. Analyses were performed according to type of malignancy and infection with methicillin-resistant S. aureus (MRSA). Data was evaluated using competing risk analyses to identify risk factors associated to 30-day mortality and used to create a point system for mortality risk stratification.

Results

We included 450 patients and MRSA was documented in 21.1%. Hospital-acquired infection, healthcare-associated pneumonia, and type-2 diabetes were associated to MRSA. In patients with hematologic malignancies, MRSA was more frequent if hospital-acquired, but less likely in primary bacteremia. Variables associated to mortality included abdominal source of infection, hematologic malignancy, MRSA, glucose levels > 140 mg/dL, and infectious endocarditis; catheter removal and initiation of adequate treatment within 48 h of positive blood culture were protective factors. From our designed mortality prediction scale, patients with a score > 3 had a 70.23% (95%CI 47.2–85.3%) probability of infection-related death at 30 days.

Conclusion

SABIs are a significant health burden for cancer patients. Risk factors for SABI-related mortality in this population are varied and impose a challenge for management to improve patient’s outcomes. Risk stratification might be useful to evaluate 30-day mortality risk.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Keynan Y, Rubinstein E (2013) Staphylococcus aureus bacteremia, risk factors, complications, and management. Crit Care Clin 29(3):547–562CrossRef Keynan Y, Rubinstein E (2013) Staphylococcus aureus bacteremia, risk factors, complications, and management. Crit Care Clin 29(3):547–562CrossRef
3.
Zurück zum Zitat van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB (2012) Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev 25(2):362–386CrossRef van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB (2012) Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev 25(2):362–386CrossRef
4.
Zurück zum Zitat Yilmaz M, Elaldi N, Balkan İİ et al (2016) Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study. Ann Clin Microbiol Antimicrob 9(15):7CrossRef Yilmaz M, Elaldi N, Balkan İİ et al (2016) Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study. Ann Clin Microbiol Antimicrob 9(15):7CrossRef
5.
Zurück zum Zitat Lesens O, Methlin C, Hansmann Y, Remy V, Martinot M, Bergin C, Meyer P, Christmann D (2003) Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol 24(12):890–896CrossRef Lesens O, Methlin C, Hansmann Y, Remy V, Martinot M, Bergin C, Meyer P, Christmann D (2003) Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol 24(12):890–896CrossRef
7.
Zurück zum Zitat González-Barca E, Carratalà J, Mykietiuk A, Fernández-Sevilla A, Gudiol F (2001) Predisposing factors and outcome of Staphylococcus aureus bacteremia in neutropenic patients with cancer. Eur J Clin Microbiol Infect Dis 20(2):117–119CrossRef González-Barca E, Carratalà J, Mykietiuk A, Fernández-Sevilla A, Gudiol F (2001) Predisposing factors and outcome of Staphylococcus aureus bacteremia in neutropenic patients with cancer. Eur J Clin Microbiol Infect Dis 20(2):117–119CrossRef
8.
Zurück zum Zitat Skov R, Gottschau A, Skinhøj P, Frimodt-Møller N, Rosdahl VT, Espersen F (1995) Staphylococcus aureus bacteremia: a 14-year nationwide study in hematological patients with malignant disease or agranulocytosis. Scand J Infect Dis 27(6):563–568CrossRef Skov R, Gottschau A, Skinhøj P, Frimodt-Møller N, Rosdahl VT, Espersen F (1995) Staphylococcus aureus bacteremia: a 14-year nationwide study in hematological patients with malignant disease or agranulocytosis. Scand J Infect Dis 27(6):563–568CrossRef
9.
Zurück zum Zitat Marín M, Gudiol C, Garcia-Vidal C, Ardanuy C, Carratalà J (2014) Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center. Medicine (Baltimore) 93(3):143–149CrossRef Marín M, Gudiol C, Garcia-Vidal C, Ardanuy C, Carratalà J (2014) Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center. Medicine (Baltimore) 93(3):143–149CrossRef
10.
Zurück zum Zitat Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, Bashore T, Corey GR (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30(4):633–638CrossRef Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, Bashore T, Corey GR (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30(4):633–638CrossRef
11.
Zurück zum Zitat Paul M, Kariv G, Goldberg E, Raskin M, Shaked H, Hazzan R, Samra Z, Paghis D, Bishara J, Leibovici L (2010) Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 65(12):2658–2665CrossRef Paul M, Kariv G, Goldberg E, Raskin M, Shaked H, Hazzan R, Samra Z, Paghis D, Bishara J, Leibovici L (2010) Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 65(12):2658–2665CrossRef
12.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRef
13.
Zurück zum Zitat Scrucca L, Santucci A, Aversa F (2010) Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant 45(9):1388–1395CrossRef Scrucca L, Santucci A, Aversa F (2010) Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant 45(9):1388–1395CrossRef
14.
Zurück zum Zitat Rolston KV (2017) Infections in cancer patients with solid tumors: a review. Infect Dis Ther 6(1):69–83CrossRef Rolston KV (2017) Infections in cancer patients with solid tumors: a review. Infect Dis Ther 6(1):69–83CrossRef
15.
Zurück zum Zitat Zakhour R, Chaftari AM, Raad II (2016) Catheter-related infections in patients with haematological malignancies: novel preventive and therapeutic strategies. Lancet Infect Dis 16(11):e241–e250CrossRef Zakhour R, Chaftari AM, Raad II (2016) Catheter-related infections in patients with haematological malignancies: novel preventive and therapeutic strategies. Lancet Infect Dis 16(11):e241–e250CrossRef
16.
Zurück zum Zitat Kang CI, Song JH, Chung DR, Korean Network for Study on Infectious Diseases (KONSID) et al (2012) Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia. Support Care Cancer 20(10):2371–2378CrossRef Kang CI, Song JH, Chung DR, Korean Network for Study on Infectious Diseases (KONSID) et al (2012) Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia. Support Care Cancer 20(10):2371–2378CrossRef
17.
Zurück zum Zitat Mehl A, Åsvold BO, Kümmel A, Lydersen S, Paulsen J, Haugan I, Solligård E, Damås JK, Harthug S, Edna TH (2017) Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study. BMC Infect Dis 17(1):116CrossRef Mehl A, Åsvold BO, Kümmel A, Lydersen S, Paulsen J, Haugan I, Solligård E, Damås JK, Harthug S, Edna TH (2017) Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study. BMC Infect Dis 17(1):116CrossRef
18.
Zurück zum Zitat Park KH, Cho OH, Lee SO, Choi SH, Kim YS, Woo JH, Kim MN, Lee DH, Suh C, Kim DY, Lee JH, Lee JH, Lee KH, Kim SH (2010) Outcome of attempted Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia. Ann Hematol 89(11):1163–1169CrossRef Park KH, Cho OH, Lee SO, Choi SH, Kim YS, Woo JH, Kim MN, Lee DH, Suh C, Kim DY, Lee JH, Lee JH, Lee KH, Kim SH (2010) Outcome of attempted Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia. Ann Hematol 89(11):1163–1169CrossRef
19.
Zurück zum Zitat Mahajan SN, Shah JN, Hachem R, Tverdek F, Adachi JA, Mulanovich V, Rolston KV, Raad II, Chemaly RF (2012) Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center. Oncologist 17(10):1329–1336CrossRef Mahajan SN, Shah JN, Hachem R, Tverdek F, Adachi JA, Mulanovich V, Rolston KV, Raad II, Chemaly RF (2012) Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center. Oncologist 17(10):1329–1336CrossRef
20.
Zurück zum Zitat Bello-Chavolla OY, Rojas-Martinez R, Aguilar-Salinas CA, Hernández-Avila M (2017) Epidemiology of diabetes mellitus in Mexico. Nutr Rev 75(suppl 1):4–12CrossRef Bello-Chavolla OY, Rojas-Martinez R, Aguilar-Salinas CA, Hernández-Avila M (2017) Epidemiology of diabetes mellitus in Mexico. Nutr Rev 75(suppl 1):4–12CrossRef
21.
Zurück zum Zitat Forsblom E, Ruotsalainen E, Järvinen A (2017) Prognostic impact of hyperglycemia at onset of methicillin-sensitive Staphylococcus aureus bacteraemia. Eur J Clin Microbiol Infect Dis 36(8):1405–1413CrossRef Forsblom E, Ruotsalainen E, Järvinen A (2017) Prognostic impact of hyperglycemia at onset of methicillin-sensitive Staphylococcus aureus bacteraemia. Eur J Clin Microbiol Infect Dis 36(8):1405–1413CrossRef
22.
Zurück zum Zitat Ayau P, Bardossy AC, Sanchez G, Ortiz R, Moreno D, Hartman P, Rizvi K, Prentiss TC, Perri MB, Mahan M, Huang V, Reyes K, Zervos MJ (2017) Risk factors for 30-day mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infections. Int J Infect Dis 61:3–6CrossRef Ayau P, Bardossy AC, Sanchez G, Ortiz R, Moreno D, Hartman P, Rizvi K, Prentiss TC, Perri MB, Mahan M, Huang V, Reyes K, Zervos MJ (2017) Risk factors for 30-day mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infections. Int J Infect Dis 61:3–6CrossRef
23.
Zurück zum Zitat Venditti M, Falcone M, Micozzi A, Carfagna P, Taglietti F, Serra PF, Martino P (2003) Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study. Haematologica 88(8):923–930PubMed Venditti M, Falcone M, Micozzi A, Carfagna P, Taglietti F, Serra PF, Martino P (2003) Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study. Haematologica 88(8):923–930PubMed
24.
Zurück zum Zitat Schelenz S, Nwaka D, Hunter PR (2013) Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance. J Antimicrob Chemother 68(6):1431–1438CrossRef Schelenz S, Nwaka D, Hunter PR (2013) Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance. J Antimicrob Chemother 68(6):1431–1438CrossRef
25.
Zurück zum Zitat Kumarachandran G, Johnson JK, Shirley DA, Graffunder E, Heil EL (2017) Predictors of adverse outcomes in children with Staphylococcus aureus bacteremia. J Pediatr Pharmacol Ther 22(3):218–226PubMedPubMedCentral Kumarachandran G, Johnson JK, Shirley DA, Graffunder E, Heil EL (2017) Predictors of adverse outcomes in children with Staphylococcus aureus bacteremia. J Pediatr Pharmacol Ther 22(3):218–226PubMedPubMedCentral
26.
Zurück zum Zitat Mesa Del Castillo-Payá C, Rodríguez-Esteban M et al (2018) Infective endocarditis in patients with oncological diseases. Enferm Infecc Microbiol Clin 36(2):72–77CrossRef Mesa Del Castillo-Payá C, Rodríguez-Esteban M et al (2018) Infective endocarditis in patients with oncological diseases. Enferm Infecc Microbiol Clin 36(2):72–77CrossRef
27.
Zurück zum Zitat Kukuckova E, Spanik S, Ilavska I, Helpianska L, Oravcova E, Lacka J, Krupova I, Grausova S, Koren P, Bezakova I, Grey E, Balaz M, Studena M, Kunova A, Torfs K, Trupl J, Korec S, Stopkova K, Krcmery V Jr (1996) Staphylococcal bacteremia in cancer patients: risk factors and outcome in 134 episodes prior to and after introduction of quinolones into infection prevention in neutropenia. Support Care Cancer 4(6):427–434CrossRef Kukuckova E, Spanik S, Ilavska I, Helpianska L, Oravcova E, Lacka J, Krupova I, Grausova S, Koren P, Bezakova I, Grey E, Balaz M, Studena M, Kunova A, Torfs K, Trupl J, Korec S, Stopkova K, Krcmery V Jr (1996) Staphylococcal bacteremia in cancer patients: risk factors and outcome in 134 episodes prior to and after introduction of quinolones into infection prevention in neutropenia. Support Care Cancer 4(6):427–434CrossRef
Metadaten
Titel
Bloodstream infection caused by S. aureus in patients with cancer: a 10-year longitudinal single-center study
verfasst von
Omar Yaxmehen Bello-Chavolla
Jessica Paola Bahena-Lopez
Pamela Garciadiego-Fosass
Patricia Volkow
Alejandro Garcia-Horton
Consuelo Velazquez-Acosta
Diana Vilar-Compte
Publikationsdatum
08.06.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 12/2018
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4275-1

Weitere Artikel der Ausgabe 12/2018

Supportive Care in Cancer 12/2018 Zur Ausgabe

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.